Global Computer-aided Drug Discovery Market Reach $7.5 Billion by 2030 at a CAGR of 11.48%
the severe coronavirus virus (COVID-19), the cardiovascular disease sub-segment, the rapidly growing occurrence of diabetes and cancer, the sub-segment for structure-based drug design, increasing frequency of chronic and undiagnosed diseases, and Oncology are expected to drive the market for computer-aided drug discovery during the following decade. Due to growing R&D efforts by scientists, researchers, and biotech and pharmaceutical companies, the market for CADD has been predicted to experience rapid Growth.
